• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

放射性胶体联合亚甲蓝染料定位,而非金属丝定位,是用于切除活检触诊阴性乳腺病变的首选方法。

Radiocolloid in combination with methylene dye localization, rather than wire localization, is a preferred procedure for excisional biopsy of nonpalpable breast lesions.

机构信息

State Key Laboratory of Oncology in South China, Sun Yat-sen University, Guangzhou, China.

出版信息

Ann Surg Oncol. 2011 Jan;18(1):109-13. doi: 10.1245/s10434-010-1207-9. Epub 2010 Aug 3.

DOI:10.1245/s10434-010-1207-9
PMID:20680696
Abstract

BACKGROUND

Wire localization (WL) is traditionally performed before excisional biopsy for patients with nonpalpable breast lesions, but it has several disadvantages. Our current study examines whether the method of radiocolloid combined with methylene dye localization (RCML) has an advantage over WL.

MATERIALS AND METHODS

From August 2006 to May 2009, 157 patients with nonpalpable breast lesions classified as BI-RADS category 5 were enrolled in our study. Of the 157 patients, 78 were assigned to WL and 79 to RCML. The status of surgical margins, weight of specimens, length of incisions, and duration of operation were compared between these two groups.

RESULTS

All patients were diagnosed after first excisional biopsy. The patients with malignancy accounted for 55.1% in WL group, and 53.2% in RCML group. For malignant lesions, fewer patients undergoing RCML had close or involved surgical margins than did those who had WL (19.0% vs. 39.5%, P = .038). The mean weight of specimen was 45.2 g in WL group and 39.0 g in RCML group (P < .001). The mean length of incision was 44.8 mm in WL group and 36.3 mm in RCML group (P < .001). The mean time of operation was 16.3 min for WL and 14.7 min for RCML (P = .001).

CONCLUSIONS

RCML provides precise identification of the site of the nonpalpable lesion and a visible marker to the lesion for surgeons and allows rapid, easy, and accurate excision of nonpalpable breast lesions. Therefore, RCML is a promising alternative to WL.

摘要

背景

传统上,对于触诊阴性的乳腺病变患者,在进行切除活检前会进行导丝定位(WL),但它有几个缺点。我们目前的研究旨在检验放射性胶体联合亚甲蓝定位(RCML)的方法是否优于 WL。

材料和方法

2006 年 8 月至 2009 年 5 月,我们纳入了 157 例触诊阴性的乳腺病变患者,这些患者的 BI-RADS 分类为 5 类。其中,78 例患者被分配到 WL 组,79 例患者被分配到 RCML 组。我们比较了两组患者的手术切缘状态、标本重量、切口长度和手术时间。

结果

所有患者均在首次切除活检后得到诊断。在 WL 组中,恶性病变患者占 55.1%,在 RCML 组中占 53.2%。对于恶性病变,RCML 组中手术切缘接近或受累的患者比例低于 WL 组(19.0% vs. 39.5%,P =.038)。WL 组的标本平均重量为 45.2 g,RCML 组的标本平均重量为 39.0 g(P <.001)。WL 组的切口平均长度为 44.8 mm,RCML 组的切口平均长度为 36.3 mm(P <.001)。WL 组的手术时间平均为 16.3 分钟,RCML 组的手术时间平均为 14.7 分钟(P =.001)。

结论

RCML 为触诊阴性的乳腺病变提供了病变部位的精确标识和可见的病变标记,使外科医生能够快速、轻松、准确地切除触诊阴性的乳腺病变。因此,RCML 是 WL 的一种很有前途的替代方法。

相似文献

1
Radiocolloid in combination with methylene dye localization, rather than wire localization, is a preferred procedure for excisional biopsy of nonpalpable breast lesions.放射性胶体联合亚甲蓝染料定位,而非金属丝定位,是用于切除活检触诊阴性乳腺病变的首选方法。
Ann Surg Oncol. 2011 Jan;18(1):109-13. doi: 10.1245/s10434-010-1207-9. Epub 2010 Aug 3.
2
Significance of methylene blue dye for localization biopsy of nonpalpable breast lesions.亚甲蓝染料在不可触及乳腺病变定位活检中的意义
Ai Zheng. 2009 Jan;28(1):79-81. Epub 2009 Jan 9.
3
Concordance of peritumoral technetium 99m colloid and subareolar blue dye injection in breast cancer sentinel lymph node biopsy.乳腺癌前哨淋巴结活检中瘤周注射锝99m胶体与乳晕下注射蓝色染料的一致性
J Surg Res. 2007 Nov;143(1):126-9. doi: 10.1016/j.jss.2007.02.054.
4
Can methylene blue only be used in sentinel lymph node biopsy for breast cancer?亚甲蓝只能用于乳腺癌前哨淋巴结活检吗?
Breast J. 2006 Sep-Oct;12(5):428-30. doi: 10.1111/j.1075-122X.2006.00299.x.
5
Sentinel lymph node mapping of breast cancer: a case-control study of methylene blue tracer compared to isosulfan blue.乳腺癌前哨淋巴结定位:亚甲蓝示踪剂与异硫蓝对比的病例对照研究
Am Surg. 2004 Oct;70(10):872-5.
6
Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.磁共振成像引导下金属丝定位后乳腺癌再次切除率
J Am Coll Surg. 2005 Apr;200(4):527-37. doi: 10.1016/j.jamcollsurg.2004.12.013.
7
Experience with fine-wire localization breast biopsies for nonpalpable breast lesions detected mammographically.乳腺钼靶检查发现的不可触及乳腺病变的细针定位乳腺活检经验。
Can J Surg. 1986 Sep;29(5):315-8.
8
[Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].[亚甲蓝染料在乳腺癌前哨淋巴结活检中的应用及其影响因素]
Ai Zheng. 2007 Oct;26(10):1133-7.
9
Sequential dermal-peritumoral radiocolloid injection for sentinel node biopsy for breast cancer: the University of Florida experience.序贯真皮-肿瘤周围放射性胶体注射用于乳腺癌前哨淋巴结活检:佛罗里达大学的经验
Am Surg. 2002 Aug;68(8):684-7; discussion 687-8.
10
Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.亚甲蓝染料在乳腺癌患者前哨淋巴结定位中的疗效
Breast J. 2004 Sep-Oct;10(5):388-91. doi: 10.1111/j.1075-122X.2004.21360.x.

引用本文的文献

1
Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411).不可触及乳腺病变的定位技术:现状、知识空白及MELODY研究(EUBREAST-4/iBRA-NET,NCT 05559411)的理论依据
Cancers (Basel). 2023 Feb 12;15(4):1173. doi: 10.3390/cancers15041173.
2
Evaluation of Carbon Nanoparticle Suspension and Methylene Blue Localization for Preoperative Localization of Nonpalpable Breast Lesions: A Comparative Study.碳纳米颗粒悬浮液与亚甲蓝定位用于不可触及乳腺病变术前定位的评估:一项对比研究
Front Surg. 2021 Nov 23;8:757694. doi: 10.3389/fsurg.2021.757694. eCollection 2021.
3
Use of the Patent Blue and Air in the Preoperative Marking of Impalpable Breast Lesions.
专利蓝和空气在术前不可触及乳腺病变标记中的应用。
Eur J Breast Health. 2018 Dec 19;15(1):7-12. doi: 10.5152/ejbh.2018.4321. eCollection 2019 Jan.
4
Localization techniques for guided surgical excision of non-palpable breast lesions.不可触及乳腺病变引导手术切除的定位技术
Cochrane Database Syst Rev. 2015 Dec 31;2015(12):CD009206. doi: 10.1002/14651858.CD009206.pub2.
5
Patent blue and air as an alternative for resection of nonpalpable breast lesions: a case series.专利蓝与空气作为不可触及乳腺病变切除术的替代方法:病例系列
Sao Paulo Med J. 2014;132(1):10-4. doi: 10.1590/1516-3180.2014.1321559.